Herpes Genitalis

16 registered clinical trials studyying Herpes Genitalis.

Status	Trial	Sponsor	Phase
Completed	An Epidemiological Study to Assess Performance of Using Healthcare Tools to Understand Genital Herpes Simplex NCT04950712	GlaxoSmithKline	—
Completed	Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection NCT04165122	Heidelberg ImmunoTherapeutics GmbH	Phase 2
Unknown	Safety and Efficacy of Laser Therapy in Gynaecology NCT04073082	Juna d.o.o.	—
Completed	Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection NCT04664127	Nearmedic Plus LLC	—
Completed	Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine NCT02837575	Vical	Phase 2
Completed	A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes NCT00486200	Astellas Pharma Inc	Phase 2
Completed	Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda NCT00405821	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the NCT02852876	Astellas Pharma Europe Ltd.	Phase 1
Completed	A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes NCT00076232	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3
Completed	Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding NCT00158509	French National Agency for Research on AIDS and Viral Hepatitis	Phase 2
Completed	A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 G NCT00158860	GlaxoSmithKline	Phase 4
Terminated	A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Person NCT00079911	GlaxoSmithKline	Phase 4
Completed	Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) NCT00158483	French National Agency for Research on AIDS and Viral Hepatitis	Phase 2
Terminated	Effect of Male Circumcision on HIV Incidence (ANRS 1265) NCT00122525	French National Agency for Research on AIDS and Viral Hepatitis	Phase 3
Unknown	A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients NCT00005663	Glaxo Wellcome	Phase 3
Completed	HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, Peru NCT00023582	National Institute of Allergy and Infectious Diseases (NIAID)	—